Skip to main content
Erschienen in: Aesthetic Plastic Surgery 4/2018

08.05.2018 | Original Article

Effectiveness and Safety of Hyaluronic Acid Gel with Lidocaine for the Treatment of Nasolabial Folds: A Systematic Review and Meta-analysis

verfasst von: Chenglong Wang, Sisi Luan, Adriana C. Panayi, Minqiang Xin, Bobin Mi, Jie Luan

Erschienen in: Aesthetic Plastic Surgery | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Hyaluronic acid (HA) gel is a widely used dermal filler for the correction facial volume loss. The incorporation of lidocaine with HA provides a pain-relieving alternative for individuals considering facial rejuvenation. The aim of this systematic review and meta-analysis is to compare the effectiveness and safety of HA with lidocaine (HAL) with that of HA without lidocaine for the treatment of nasolabial folds (NLFs).

Methods

Studies were identified using the electronic databases PubMed, Embase, Cochrane Central Register of Controlled Trials and Web of Science from inception up to January 2018. Randomized controlled trials (RCTs) were selected based on the inclusion criteria. Outcomes included 100-mm Visual Analogue Scale (VAS) score, Wrinkle Severity Rating Scale score and adverse events.

Results

A total of 908 patients from 12 RCTs were included in the meta-analysis. VAS score within 30 min after injection in the HAL group was much lower than that with just HA group (MD = − 28.83, 95% CI − 36.38 to − 21.28). There was no significant difference in effectiveness between the two products 24 months post-injection (MD = 0.13, 95% CI − 0.15 to 0.41). The main adverse events, such as swelling, erythema, bruising, itching and induration, also showed no significant difference.

Conclusions

HAL is more effective for pain relief than HA alone, but both display similar effectiveness and safety for the correction of NLFs.

Level of Evidence II

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literatur
2.
Zurück zum Zitat Levy PM, De Boulle K, Raspaldo H (2009) Comparison of injection comfort of a new category of cohesive hyaluronic acid filler with preincorporated lidocaine and a hyaluronic acid filler alone. Dermatol Surg 35(Suppl 1):332–336 (discussion 337) CrossRefPubMed Levy PM, De Boulle K, Raspaldo H (2009) Comparison of injection comfort of a new category of cohesive hyaluronic acid filler with preincorporated lidocaine and a hyaluronic acid filler alone. Dermatol Surg 35(Suppl 1):332–336 (discussion 337) CrossRefPubMed
3.
Zurück zum Zitat Matarasso SL, Carruthers JD, Jewell ML et al (2006) Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg 117(3 Suppl):3S–34S (discussion 35S–43S) CrossRefPubMed Matarasso SL, Carruthers JD, Jewell ML et al (2006) Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg 117(3 Suppl):3S–34S (discussion 35S–43S) CrossRefPubMed
4.
Zurück zum Zitat Suh JH, Oh CT, Im SI et al (2017) A multicenter, randomized, double-blind clinical study to evaluate the efficacy and safety of a new monophasic hyaluronic acid filler with lidocaine 0.3% in the correction of nasolabial fold. J Cosmet Dermatol 16(3):327–332CrossRefPubMed Suh JH, Oh CT, Im SI et al (2017) A multicenter, randomized, double-blind clinical study to evaluate the efficacy and safety of a new monophasic hyaluronic acid filler with lidocaine 0.3% in the correction of nasolabial fold. J Cosmet Dermatol 16(3):327–332CrossRefPubMed
5.
Zurück zum Zitat Lee JH, Kim SH, Park ES (2017) The efficacy and safety of HA IDF Plus (with lidocaine) versus HA IDF (without lidocaine) in nasolabial folds injection: a randomized, multicenter, double-blind, split-face study. Aesthet Plast Surg 41(2):422–428CrossRef Lee JH, Kim SH, Park ES (2017) The efficacy and safety of HA IDF Plus (with lidocaine) versus HA IDF (without lidocaine) in nasolabial folds injection: a randomized, multicenter, double-blind, split-face study. Aesthet Plast Surg 41(2):422–428CrossRef
6.
Zurück zum Zitat Kuhne U, Esmann J, von Heimburg D et al (2016) Safety and performance of cohesive polydensified matrix hyaluronic acid fillers with lidocaine in the clinical setting—an open-label, multicenter study. Clin Cosmet Invest Dermatol 9:373–381CrossRef Kuhne U, Esmann J, von Heimburg D et al (2016) Safety and performance of cohesive polydensified matrix hyaluronic acid fillers with lidocaine in the clinical setting—an open-label, multicenter study. Clin Cosmet Invest Dermatol 9:373–381CrossRef
7.
Zurück zum Zitat Bulam H, Sezgin B, Tuncer S et al (2015) A severe acute hypersensitivity reaction after a hyaluronic acid with lidocaine filler injection to the lip. Arch Plast Surg 42(2):245–247CrossRefPubMedPubMedCentral Bulam H, Sezgin B, Tuncer S et al (2015) A severe acute hypersensitivity reaction after a hyaluronic acid with lidocaine filler injection to the lip. Arch Plast Surg 42(2):245–247CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Sharma P, Sharma S (2011) Comparative study of a new dermal filler Uma Jeunesse® and Juvederm®. J Cosmet Dermatol 10(2):118–125CrossRefPubMed Sharma P, Sharma S (2011) Comparative study of a new dermal filler Uma Jeunesse® and Juvederm®. J Cosmet Dermatol 10(2):118–125CrossRefPubMed
9.
Zurück zum Zitat Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1CrossRefPubMedPubMedCentral Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12CrossRefPubMed Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12CrossRefPubMed
11.
Zurück zum Zitat Banares R, Albillos A, Rincon D et al (2002) Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35(3):609–615CrossRefPubMed Banares R, Albillos A, Rincon D et al (2002) Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35(3):609–615CrossRefPubMed
12.
Zurück zum Zitat Royo de la Torre J, Moreno-Moraga J, Isarria MJ et al (2013) The evaluation of hyaluronic acid, with and without lidocaine, in the filling of nasolabial folds as measured by ultrastructural changes and pain management. J Drugs Dermatol 12(3):e46–e52PubMed Royo de la Torre J, Moreno-Moraga J, Isarria MJ et al (2013) The evaluation of hyaluronic acid, with and without lidocaine, in the filling of nasolabial folds as measured by ultrastructural changes and pain management. J Drugs Dermatol 12(3):e46–e52PubMed
13.
Zurück zum Zitat Weiss R, Bank D, Brandt F (2010) Randomized, double-blind, split-face study of small-gel-particle hyaluronic acid with and without lidocaine during correction of nasolabial folds. Dermatol Surg 36(s1):750–759CrossRef Weiss R, Bank D, Brandt F (2010) Randomized, double-blind, split-face study of small-gel-particle hyaluronic acid with and without lidocaine during correction of nasolabial folds. Dermatol Surg 36(s1):750–759CrossRef
14.
Zurück zum Zitat Raspaldo H, De Boulle K, Levy PM (2010) Longevity of effects of hyaluronic acid plus lidocaine facial filler. J Cosmet Dermatol 9(1):11–15CrossRefPubMed Raspaldo H, De Boulle K, Levy PM (2010) Longevity of effects of hyaluronic acid plus lidocaine facial filler. J Cosmet Dermatol 9(1):11–15CrossRefPubMed
15.
Zurück zum Zitat Monheit GD, Campbell RM, Neugent H et al (2010) Reduced pain with use of proprietary hyaluronic acid with lidocaine for correction of nasolabial folds: a patient-blinded, prospective, randomized controlled trial. Dermatol Surg 36(1):94–101CrossRefPubMed Monheit GD, Campbell RM, Neugent H et al (2010) Reduced pain with use of proprietary hyaluronic acid with lidocaine for correction of nasolabial folds: a patient-blinded, prospective, randomized controlled trial. Dermatol Surg 36(1):94–101CrossRefPubMed
16.
Zurück zum Zitat Monheit GD, Baumann LS, Gold MH et al (2010) Novel hyaluronic acid dermal filler: dermal gel extra physical properties and clinical outcomes. Dermatol Surg 36(Suppl 3):1833–1841CrossRefPubMed Monheit GD, Baumann LS, Gold MH et al (2010) Novel hyaluronic acid dermal filler: dermal gel extra physical properties and clinical outcomes. Dermatol Surg 36(Suppl 3):1833–1841CrossRefPubMed
17.
Zurück zum Zitat Lupo MP, Swetman G, Waller W (2010) The effect of lidocaine when mixed with large gel particle hyaluronic acid filler tolerability and longevity: a six-month trial. J Drugs Dermatol 9(9):1097–1100PubMed Lupo MP, Swetman G, Waller W (2010) The effect of lidocaine when mixed with large gel particle hyaluronic acid filler tolerability and longevity: a six-month trial. J Drugs Dermatol 9(9):1097–1100PubMed
18.
Zurück zum Zitat Hedén P, Fagrell D, Jernbeck J et al (2010) Injection of stabilized hyaluronic acid-based gel of non-animal origin for the correction of nasolabial folds: comparison with and without lidocaine. Dermatol Surg 36(s1):775–781CrossRef Hedén P, Fagrell D, Jernbeck J et al (2010) Injection of stabilized hyaluronic acid-based gel of non-animal origin for the correction of nasolabial folds: comparison with and without lidocaine. Dermatol Surg 36(s1):775–781CrossRef
19.
Zurück zum Zitat Brandt F, Bank D, Cross SL et al (2010) A lidocaine-containing formulation of large-gel particle hyaluronic acid alleviates pain. Dermatol Surg 36(Suppl 3):1876–1885CrossRefPubMed Brandt F, Bank D, Cross SL et al (2010) A lidocaine-containing formulation of large-gel particle hyaluronic acid alleviates pain. Dermatol Surg 36(Suppl 3):1876–1885CrossRefPubMed
20.
Zurück zum Zitat Levy PM, De Boulle K, Raspaldo H (2009) A split-face comparison of a new hyaluronic acid facial filler containing pre-incorporated lidocaine versus a standard hyaluronic acid facial filler in the treatment of naso-labial folds. J Cosmet Laser Ther 11(3):169–173CrossRefPubMed Levy PM, De Boulle K, Raspaldo H (2009) A split-face comparison of a new hyaluronic acid facial filler containing pre-incorporated lidocaine versus a standard hyaluronic acid facial filler in the treatment of naso-labial folds. J Cosmet Laser Ther 11(3):169–173CrossRefPubMed
21.
Zurück zum Zitat Weinkle SH, Bank DE, Boyd CM et al (2009) A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvederm injectable gel with and without lidocaine. J Cosmet Dermatol 8(3):205–210CrossRefPubMed Weinkle SH, Bank DE, Boyd CM et al (2009) A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvederm injectable gel with and without lidocaine. J Cosmet Dermatol 8(3):205–210CrossRefPubMed
22.
Zurück zum Zitat Day DJ, Littler CM, Swift RW et al (2004) The wrinkle severity rating scale: a validation study. Am J Clin Dermatol 5(1):49–52CrossRefPubMed Day DJ, Littler CM, Swift RW et al (2004) The wrinkle severity rating scale: a validation study. Am J Clin Dermatol 5(1):49–52CrossRefPubMed
23.
Zurück zum Zitat Brandt FS, Cazzaniga A (2008) Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging 3(1):153–159PubMedPubMedCentral Brandt FS, Cazzaniga A (2008) Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging 3(1):153–159PubMedPubMedCentral
24.
Zurück zum Zitat Choi WJ, Han SW, Kim JE et al (2015) The efficacy and safety of lidocaine-containing hyaluronic acid dermal filler for treatment of nasolabial folds: a multicenter, randomized clinical study. Aesthet Plast Surg 39(6):953–962CrossRef Choi WJ, Han SW, Kim JE et al (2015) The efficacy and safety of lidocaine-containing hyaluronic acid dermal filler for treatment of nasolabial folds: a multicenter, randomized clinical study. Aesthet Plast Surg 39(6):953–962CrossRef
25.
Zurück zum Zitat Fischer TC, Sattler G, Gauglitz GG (2016) Hyaluron filler containing lidocaine on a CPM basis for lip augmentation: reports from practical experience. Facial Plast Surg 32(3):283–288CrossRefPubMed Fischer TC, Sattler G, Gauglitz GG (2016) Hyaluron filler containing lidocaine on a CPM basis for lip augmentation: reports from practical experience. Facial Plast Surg 32(3):283–288CrossRefPubMed
26.
Zurück zum Zitat Prager W, Micheels P (2015) A prospective, comparative survey to investigate practitioners’ satisfaction with a cohesive, polydensified-matrix®, hyaluronic acid-based filler gel with and without lidocaine for the treatment of facial wrinkles. J Cosmet Dermatol 14(2):124–129CrossRefPubMed Prager W, Micheels P (2015) A prospective, comparative survey to investigate practitioners’ satisfaction with a cohesive, polydensified-matrix®, hyaluronic acid-based filler gel with and without lidocaine for the treatment of facial wrinkles. J Cosmet Dermatol 14(2):124–129CrossRefPubMed
27.
Zurück zum Zitat Andre P (2004) Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA—Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol 18(4):422–425CrossRefPubMed Andre P (2004) Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA—Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol 18(4):422–425CrossRefPubMed
28.
Zurück zum Zitat Chopra R, Graivier M, Fabi S et al (2018) A multi-center, open-label, prospective study of cannula injection of small-particle hyaluronic acid plus lidocaine (SPHAL) for lip augmentation. J Drugs Dermatol 17(1):10–16PubMed Chopra R, Graivier M, Fabi S et al (2018) A multi-center, open-label, prospective study of cannula injection of small-particle hyaluronic acid plus lidocaine (SPHAL) for lip augmentation. J Drugs Dermatol 17(1):10–16PubMed
Metadaten
Titel
Effectiveness and Safety of Hyaluronic Acid Gel with Lidocaine for the Treatment of Nasolabial Folds: A Systematic Review and Meta-analysis
verfasst von
Chenglong Wang
Sisi Luan
Adriana C. Panayi
Minqiang Xin
Bobin Mi
Jie Luan
Publikationsdatum
08.05.2018
Verlag
Springer US
Erschienen in
Aesthetic Plastic Surgery / Ausgabe 4/2018
Print ISSN: 0364-216X
Elektronische ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-018-1149-3

Weitere Artikel der Ausgabe 4/2018

Aesthetic Plastic Surgery 4/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.